Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Clinical trial NCT05835687 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05835687
Sponsor: St. Jude Children's Research Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Neoplasms Atypical Teratoid/Rhabdoid Tumor Diffuse Midline Glioma, H3 K27M-Mutant Ependymoma High Grade Glioma Glioblastoma Medulloblastoma

Start date: 2023-04-27
Primary completion: 2026-06-04
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.